| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT04428879 |
| P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
| P17 | country | Canada | Q16 |
| P582 | end time | 2025-10-15 | |
| P921 | main subject | eye disease | Q3041498 |
| P4135 | maximum age | 17 | |
| P1050 | medical condition | retinoblastoma | Q500695 |
| P1132 | number of participants | 30 | |
| P4844 | research intervention | topotecan | Q419953 |
| P8005 | research subject recruitment status | recruiting | Q76649708 |
| P1813 | short name | STEP-RB | |
| P580 | start time | 2020-06-16 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Phase I Sustained-Release Topotecan Episcleral Plaque (Chemoplaque) for Retinoblastoma |
Search more.